Champions Oncology Statistics
Total Valuation
CSBR has a market cap or net worth of $81.93 million. The enterprise value is $80.64 million.
Important Dates
The last earnings date was Thursday, March 12, 2026, after market close.
| Earnings Date | Mar 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CSBR has 13.89 million shares outstanding. The number of shares has decreased by -1.39% in one year.
| Current Share Class | 13.89M |
| Shares Outstanding | 13.89M |
| Shares Change (YoY) | -1.39% |
| Shares Change (QoQ) | -3.95% |
| Owned by Insiders (%) | 26.50% |
| Owned by Institutions (%) | 12.16% |
| Float | 5.19M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.43 |
| Forward PS | 1.83 |
| PB Ratio | 19.52 |
| P/TBV Ratio | 20.96 |
| P/FCF Ratio | 21.69 |
| P/OCF Ratio | 18.84 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.39 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 21.13 |
Financial Position
The company has a current ratio of 0.98, with a Debt / Equity ratio of 1.14.
| Current Ratio | 0.98 |
| Quick Ratio | 0.93 |
| Debt / Equity | 1.14 |
| Debt / EBITDA | 4.86 |
| Debt / FCF | 1.31 |
| Interest Coverage | -82.30 |
Financial Efficiency
Return on equity (ROE) is -47.59% and return on invested capital (ROIC) is -131.60%.
| Return on Equity (ROE) | -47.59% |
| Return on Assets (ROA) | -4.70% |
| Return on Invested Capital (ROIC) | -131.60% |
| Return on Capital Employed (ROCE) | -28.60% |
| Weighted Average Cost of Capital (WACC) | 6.13% |
| Revenue Per Employee | $272,042 |
| Profits Per Employee | -$11,000 |
| Employee Count | 213 |
| Asset Turnover | 1.96 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -55,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -25.32% in the last 52 weeks. The beta is 0.40, so CSBR's price volatility has been lower than the market average.
| Beta (5Y) | 0.40 |
| 52-Week Price Change | -25.32% |
| 50-Day Moving Average | 5.92 |
| 200-Day Moving Average | 6.56 |
| Relative Strength Index (RSI) | 48.56 |
| Average Volume (20 Days) | 7,316 |
Short Selling Information
The latest short interest is 81,985, so 0.59% of the outstanding shares have been sold short.
| Short Interest | 81,985 |
| Short Previous Month | 81,893 |
| Short % of Shares Out | 0.59% |
| Short % of Float | 1.58% |
| Short Ratio (days to cover) | 8.57 |
Income Statement
In the last 12 months, CSBR had revenue of $57.95 million and -$2.34 million in losses. Loss per share was -$0.17.
| Revenue | 57.95M |
| Gross Profit | 26.58M |
| Operating Income | -2.22M |
| Pretax Income | -2.40M |
| Net Income | -2.34M |
| EBITDA | -772,000 |
| EBIT | -2.22M |
| Loss Per Share | -$0.17 |
Full Income StatementBalance Sheet
The company has $7.13 million in cash and $5.00 million in debt, giving a net cash position of $2.13 million or $0.15 per share.
| Cash & Cash Equivalents | 7.13M |
| Total Debt | 5.00M |
| Net Cash | 2.13M |
| Net Cash Per Share | $0.15 |
| Equity (Book Value) | 4.38M |
| Book Value Per Share | 0.31 |
| Working Capital | -492,000 |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $4.39 million and capital expenditures -$578,000, giving a free cash flow of $3.82 million.
| Operating Cash Flow | 4.39M |
| Capital Expenditures | -578,000 |
| Depreciation & Amortization | 1.45M |
| Net Borrowing | -154,000 |
| Free Cash Flow | 3.82M |
| FCF Per Share | $0.27 |
Full Cash Flow StatementMargins
Gross margin is 45.88%, with operating and profit margins of -3.83% and -4.04%.
| Gross Margin | 45.88% |
| Operating Margin | -3.83% |
| Pretax Margin | -4.14% |
| Profit Margin | -4.04% |
| EBITDA Margin | -1.33% |
| EBIT Margin | -3.83% |
| FCF Margin | 6.59% |